Remove Arrhythmia Remove Defibrillator Remove Sudden Cardiac Death
article thumbnail

Appropriate use of wearable defibrillators with multiparametric evaluation to avoid unnecessary defibrillator implantation

Open Heart

Introduction Wearable cardioverter-defibrillators (WCD) have emerged as a valuable tool in the management of patients at risk for life-threatening arrhythmias. These devices offer a non-invasive and temporary solution, providing continuous monitoring and the potential for prompt defibrillation when needed.

article thumbnail

Epicardial Substrate Ablation in Symptomatic Brugada Syndrome Patients: An Updated Systematic Review and Single-arm Meta-analysis

HeartRhythm

Brugada syndrome (BrS) is a genetic heart disease that predisposes individuals to ventricular arrhythmias and sudden cardiac death. Although implantable cardioverter-defibrillators (ICDs) and quinidine are primary treatments, recurrent BrS-triggered ventricular arrhythmias can persist.

article thumbnail

Understanding the Difference Between Heart Attack and Cardiac Arrest

MIBHS

Without immediate intervention, sudden cardiac death can occur within minutes. Signs include: Sudden loss of consciousness No pulse or breathing Collapse without prior chest pain or discomfort If someone experiences sudden cardiac arrest, it is crucial to begin CPR immediately and call the local emergency number.

article thumbnail

ECG Blog #436 — Bigeminy or Alternans?

Ken Grauer, MD

He developed cardiac arrest shortly after the ECG in Figure-1 was recorded. What is the most likely cause of this arrhythmia? C ASE C onclusion: As noted above — today's patient developed cardiac arrest shortly after arrival in the ED. QUESTIONS: How would YOU interpret the ECG in Figure-1 ?

Blog 159
article thumbnail

EV ICD Global Pivotal Trial Results Demonstrate High ATP Success, Effective Defibrillation

DAIC

2, 2024 – Medtronic recently shared long-term results from the global Extravascular Implantable Cardioverter Defibrillator (EV ICD) Pivotal Trial, reinforcing the performance and safety of the EV-ICD system. chief medical officer of the Cardiac Rhythm Management business, which is part of the Cardiovascular Portfolio at Medtronic.

article thumbnail

Expanded application of wearable cardioverter defibrillators beyond current guidelines: proposal for a European register explained through single clinical scenarios

Open Heart

The wearable cardioverter defibrillator (WCD) is becoming a more and more widely used instrument for the prevention of sudden cardiac death of patients either with a secondary prevention implantable cardioverter defibrillator indication or with a transient high risk of sudden cardiac death.

article thumbnail

MP-470553-004 ADVERSE EVENTS ASSOCIATED WITH WEARABLE CARDIOVERTER-DEFIBRILLATOR (LIFEVEST): A FOOD AND DRUG ADMINISTRATION MAUDE DATABASE STUDY

HeartRhythm

Wearable cardioverter-defibrillator (WCD) is an alternative option for the prevention of sudden cardiac death in patients at high risk for malignant ventricular arrhythmias.